visceral adipose tissue raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-10-05 and is reviewed periodically as new material appears.
Signaling begins at the GHRH receptor, a class B G protein-coupled receptor displayed on somatotroph cells of the anterior pituitary. Receptor occupancy activates Gs proteins, which raise adenylyl cyclase activity and intracellular cyclic AMP, in turn driving protein kinase A dependent pathways. The downstream output is synthesis and pulsatile secretion of growth hormone into the bloodstream. Hepatic tissue and peripheral sites respond by increasing insulin-like growth factor 1 production. Somatostatin and IGF-1 itself supply negative feedback that caps the size and duration of each secretory burst.
Metabolic interest in this compound centers on fat distribution rather than on hormone levels alone. Imaging trials in adults with excess abdominal fat report reductions in visceral adipose tissue, while subcutaneous depots change comparatively little. Growth hormone and IGF-1 are presumed to carry the effect, but the separate contribution of each is not firmly established. Whether these changes persist after treatment stops, and whether they alter longer-term health outcomes, remain open questions that published work does not answer consistently.
Tesamorelin is a synthetic peptide of forty-four amino acids whose sequence reproduces human growth hormone-releasing hormone. Its distinguishing feature sits at the amino terminus, where a trans-3-hexenoyl group replaces the free amine. That acylation slows cleavage by dipeptidyl peptidase IV, an enzyme that otherwise removes the first two residues and inactivates the natural hormone quickly. The modified peptide therefore persists longer in circulation while keeping the same receptor target. It is handled as a lyophilized solid and dissolved shortly before use.
Practical handling centers on limiting moisture, oxygen, and temperature excursions. Lyophilized material is generally held at or below minus twenty degrees Celsius, protected from light and kept sealed until use. Once reconstituted, solutions are typically kept cold and used within a short window because hydrolysis and microbial growth both accelerate in liquid form. Repeated freeze-thaw cycles are avoided, since they promote aggregation. Vial contents should be inspected for particulates and clarity before analysis, and working aliquots are prepared to reduce the number of times the stock is opened.
Quantitation of the peptide relies mainly on reversed-phase high-performance liquid chromatography with ultraviolet detection, typically at 214 nanometers, where the peptide bond absorbs. Identity is confirmed by mass spectrometry, most often electrospray ionization coupled to liquid chromatography, and by peptide mapping after enzymatic digestion. Because related impurities differ only slightly in sequence or modification, method development emphasizes resolution rather than speed. Purity is usually reported as a percentage of the main peak area, with individual impurities listed separately when they exceed a defined reporting threshold.
Stability testing examines how the molecule changes under controlled stress. Thermal stress, light exposure, and extremes of pH are applied separately so that each degradation route can be attributed to a specific cause. The main observed changes are oxidation, deamidation, and aggregation into dimers or higher-order species. Accelerated studies at elevated temperature are used to estimate behavior over longer periods, though such extrapolation carries uncertainty. For a lyophilized powder, residual moisture and the choice of bulking agent strongly influence how quickly these changes appear.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic 44-residue peptide | GHRH analog backbone |
| Approximate molecular mass | 5136 Da | Varies with counterion and hydration state |
| N-terminal group | trans-3-hexenoyl | Increases resistance to dipeptidyl peptidase IV |
| Primary receptor | GHRH receptor (GHRHR) | Class B G protein-coupled receptor on somatotrophs |
| Principal mediator | IGF-1 | Rises indirectly after growth hormone release |
Receptor-level activity begins when the peptide binds the GHRH receptor, a class B G-protein-coupled receptor found on pituitary somatotroph cells. Occupancy triggers Gs-mediated activation of adenylyl cyclase and a rise in intracellular cyclic AMP, which in turn promotes synthesis and pulsatile release of growth hormone. Because the compound acts upstream of the growth hormone axis rather than supplying hormone directly, its effect depends on intact pituitary function. Binding studies in cell culture and animal models have established this pathway; the detailed kinetics of receptor recycling in humans remain less well characterized.
Physicochemical behavior is dominated by the peptide backbone. The molecule is hydrophilic and carries a net positive charge near neutral pH, owing to several arginine and lysine residues. In solution it adopts a largely unstructured conformation, and aggregation is a known concern for peptide products of this size. Oxidation of methionine and deamidation of asparagine or glutamine residues are the principal chemical degradation routes. These liabilities shape how the material is formulated, handled, and analyzed, and they explain why lyophilized presentations are common in research settings.
Published work tends to frame tesamorelin as a tool for studying the GHRH axis and as a compound with measurable effects on body composition. Reports often describe visceral adipose tissue as an endpoint, assessed by imaging rather than by inference. Analytical sections commonly describe liquid chromatography with tandem mass spectrometry to confirm identity and purity, because immunoassays may cross-react with related fragments. Where results diverge between studies, differences in assay choice, sampling timing, and population are frequent explanations offered. Whether effects persist after treatment stops remains an open question.
Tesamorelin binds the growth hormone–releasing hormone receptor on pituitary somatotroph cells. The receptor signals through the Gs protein, raising intracellular cAMP and activating protein kinase A. That cascade triggers release of stored growth hormone in pulses rather than a steady stream. Because the drug acts at the receptor that normally controls this process, its effect depends on the body's own signaling architecture rather than on a synthetic pathway. The resulting hormone profile reflects the timing of each pulse, not only its size.
The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
Experiments to date have supported the theory, with the half-lives of the confirmed nihonium isotopes increasing from milliseconds to seconds as neutrons are added and the island is approached. Nihonium has been calculated to have similar properties to its homologues boron, aluminium, gallium, indium, and thallium. All but boron are post-transition metals, and nihonium is expected to be a post-transition metal as well. It should also show several major differences from them; for example, nihonium should be more stable in the +1 oxidation state than the +3 state, like thallium, but in the +1 state nihonium should behave more like silver and astatine than thallium. Preliminary experiments have shown that elemental nihonium is not very volatile, and that it is less reactive than its lighter homologue thallium.
Hardee's was purchased by Canadian company Imasco Limited in 1981. In 1982, General Foods sold Burger Chef to Imasco for $44 million. Imasco converted many locations to Hardee's restaurants and let franchises and locations near existing Hardee's locations convert to other brands. Remaining restaurants that did not convert to Hardee's or new names and branding simply closed. A new management team, in the early 1980s, seeking to cut costs, changed the signature burger recipe and eliminated the flagship menu item, the Big Twin. The Big Deluxe continued to be offered throughout the 1990s. For a few years after acquiring the Roy Rogers Restaurants fast food chain in the early 1990s, Hardee's outlets sold fried chicken prepared using the popular Roy Rogers Restaurant recipe hoping it could compete with KFC. In addition to Roy Rogers, Hardee's also owned Rax Roast Beef for a period of time and sold roast beef sandwiches throughout the Hardee's system.
== Mechanism of action == Levosimendan is a calcium sensitizer — it increases the sensitivity of the heart to calcium, thus increasing cardiac contractility without a rise in intracellular calcium. Levosimendan exerts its positive inotropic effect by increasing calcium sensitivity of myocytes by binding to cardiac troponin C in a calcium-dependent manner. It also has a vasodilatory effect, by opening adenosine triphosphate (ATP)-sensitive potassium channels in vascular smooth muscle to cause smooth muscle relaxation. The combined inotropic and vasodilatory actions result in an increased force of contraction, decreased preload and decreased afterload. Moreover, by opening also the mitochondrial (ATP)-sensitive potassium channels in cardiomyocytes, the drug exerts a cardioprotective effect.
==== Host genetic factors ==== The organism that is the target of an infecting action of a specific infectious agent is called the host. The host harboring an agent that is in a mature or sexually active stage phase is called the definitive host. The intermediate host comes in contact during the larvae stage. A host can be anything living and can attain to asexual and sexual reproduction. The clearance of the pathogens, either treatment-induced or spontaneous, can be influenced by the genetic variants carried by individual patients. For instance, for genotype 1 hepatitis C treated with Pegylated interferon-alpha-2a or Pegylated interferon-alpha-2b (brand names Pegasys or PEG-Intron) combined with ribavirin, it has been shown that genetic polymorphisms near the human IL28B gene, encoding interferon lambda 3, are associated with significant differences in the treatment-induced clearance of the virus. This finding, originally reported in Nature, showed that genotype 1 hepatitis C patients carrying certain genetic variant alleles near the IL28B gene are more likely to achieve a sustained virological response after treatment than others. Later report from Nature demonstrated that the same genetic variants are also associated with the natural clearance of the genotype 1 hepatitis C virus.
https://www.bioinformatics.nl/tools/pam.html Website that calculates a PAM matrix for any level. https://ftp.ncbi.nih.gov/repository/blocks/unix/blosum/MDM/ for PAM matrices from 1992 (PAM80, 120, 160, 210, 250 calculated using the "pam" program and PAM250 from Gonnet, Cohen & Benner 1992) https://www.ncbi.nlm.nih.gov/IEB/ToolBox/C_DOC/lxr/source/data/ for PAM30, PAM70, and PAM250 in the NCBI C Toolkit. https://github.com/ncbi/ncbi-cxx-toolkit-public/tree/main/src/util/tables for the same tables in the NCBI C++ Toolkit. https://ftp.ncbi.nih.gov/blast/matrices/ NCBI "Bonus Matrices" for BLAST, includes PAM10–500 and many other matrices. Also includes the source code for the "pam" program, which multiplies the data from Dayhoff to extrapolate other PAM values. Later derivations of PAM-type matrices:
Sources: en.wikipedia.org
Mazda's automotive plans for the early sixties consisted of growing alongside the Japanese economy. To achieve this goal, they began by building an extremely affordable kei car, the R360 in 1960, planning on introducing gradually larger and pricier cars as the Japanese customers became able to afford them. As a preview, testing the waters, a larger "Mazda 700" prototype was shown at the eighth Tokyo Motor Show in 1961, and formed the basis for the upcoming Mazda Familia. Meanwhile, the four door version of the R360 was introduced as the Mazda Carol, which appeared in 1962, and discontinued in 1964. The first production Familia, styled by a young Giorgetto Giugiaro while working at Carrozzeria Bertone, appeared in October 1963. In line with Mazda's policy of only gradually approaching the production of private cars (a luxury in Japan at the time), the first Familia was initially only available as a commercial two-door wagon called the Familia van. The van was joined in April 1964 by a plusher Familia wagon, in October by a four-door saloon, and in November by a two-door saloon. The "flat deck" design of the saloon versions was reportedly inspired by the Chevrolet Corvair. Private car versions received foglights in the grille as well as more chrome trim. The Familia was sold in other markets as the 800. The Familia was introduced to the Japanese market in time for the 1964 Summer Olympics which began in October. The cars used a 782 cc, "SA" four-stroke aluminum straight-four engine, also known as the "white engine".
The cause of Fukuyama congenital muscular dystrophy is rooted in the FKTN gene, located at human chromosome 9q31, encoding the protein fukutin. Mutations in this gene, and therefore the fukutin protein, are the cause of FCMD. The disease is inherited in an autosomal recessive manner. This means the defective gene responsible for the disorder is located on an autosome (chromosome 9 is an autosome), and two copies of the defective gene (one inherited from each parent) are required in order to be born with the disorder. The parents of an individual with an autosomal recessive disorder both carry one copy of the defective gene but usually do not experience any signs or symptoms of the disorder. Two mutations have been identified. The first and most common is an SVA retrotransposal insertion in the 3'-untranslated region. The second is a deep-intronic point mutation c.647+2084G>T. This second mutation has only been found to date in the presence of the first mutation.
Double-decker bus The approximate volume of a double-decker bus, abbreviated to DDB, has been used informally to describe the size of hole created by a major sewer collapse. For example, a report might refer to "a 4 DDB hole". Olympic-size swimming pool For larger volumes of liquid, one measure commonly used in the media in many countries is the Olympic-size swimming pool. A 50 m × 25 m (164 ft × 82 ft) Olympic swimming pool, built to the FR3 minimum depth of 2 metres (6.6 ft) would hold 2,500 m3 (660,000 US gal). The US National Institute of Standards and Technology (NIST) defines the Olympic swimming pool as 1 million litres, which is the approximate volume of the smaller FR2 pool. Royal Albert Hall The Royal Albert Hall, a large concert hall, is sometimes used as a unit of volume in the UK, for example when referring to volumes of rubbish placed in landfill. It is famously used in the line "Now they know how many holes it takes to fill the Albert Hall." in The Beatles song "A Day in the Life". The volume of the auditorium is between 3 and 3.5 million cubic feet (between 85,000 and 99,000 cubic metres). Melbourne Cricket Ground A common measure of volume in Australia, and in the state of Victoria in particular, is the Melbourne Cricket Ground, the largest stadium in Australia and 13th largest in the world. The volume of the Melbourne Cricket Ground is 1,574,000 cubic metres, or about 630 Olympic swimming pools. Its seating capacity (100,000 as of July 2019) is also used as a unit measure of the number of people.
US EPA: Per- and Polyfluoroalkyl Substances (PFAS) – Overview, regulatory actions, tools & resources Sustained Outrage Blog – C8 (PFOA) Category Archived 2010-04-02 at the Wayback Machine published by the Charleston Gazette Perfluorooctanoic Acid (PFOA); Fluorinated Telomers enforceable consent agreement development Perfluorinated substances and their uses in Sweden Chain of Contamination: The Food Link, Perfluorinated Chemicals (PFCs) Incl. PFOS & PFOA
Sources: en.wikipedia.org
UPMC Altoona, located in Altoona, Pennsylvania, is a 361-bed, non-profit, private community hospital system that contains more than 20 affiliated health care companies and functions as the regional referral center and tertiary hub of UPMC in west central Pennsylvania.
== History == Loren Pickart (1938–2023) isolated the copper peptide GHK-Cu from human plasma albumin in 1973. It was noticed that liver tissue obtained from patients aged 60 to 80 years had an increased level of fibrinogen. However, when liver cells from old patients were incubated in the blood from the younger group, the older cells started functioning in nearly the same way as the younger liver tissue. It turned out that this effect was due to a small peptide factor that behaved similarly to the synthetic peptide glycyl-L-histidyl-L-lysine (GHK). Pickart proposed that this activity in human plasma albumin was a tripeptide glycyl-L-histidyl-L-lysine and that it might function by chelating metal ions. In 1977, the growth modulating peptide was shown to be a glycyl-L-histidyl-L-lysine. It is proposed that GHK-Cu modulates copper intake into cells.
==== United States of America ==== The U.S. Drug Enforcement Administration issued a temporary order for the classification of desmetramadol in schedule 1 of the Controlled Substances Act for the period of August 12, 2026 through August 12, 2028.
== Work == Ruhrarbeiter gegen den Faschismus Dokumentation über den Widerstand im Ruhrgebeit 1933–1945, Frankfurt am Main, 1976. Die Reihen fast geschlossen: Beiträge zur Geschichte des Alltags unterm Nationalsozialismus co-edited with Jürgen Reulecke & Adelheid Gräfin zu Castell-Rüdenhausen, Wuppertal: Hammer, 1981. Volksgenossen und Gemeinschaftsfremde: Anpassung, Ausmerze und Aufbegehren unter dem Nationalsozialismus Cologne: Bund Verlag, 1982, translated into English by Richard Deveson as Inside Nazi Germany: Conformity, Opposition and Racism in Everyday Life London: Batsford, 1987 ISBN 0-7134-5217-X. Die Weimarer Republik : Krisenjahre der Klassischen Moderne, Frankfurt am Main: Suhrkamp Verlag, 1987 translated into English as The Weimar Republic: the Crisis of Classical Modernity, New York : Hill and Wang, 1992 ISBN 0-8090-9674-9. “The Genesis of the `Final Solution’ from the Spirit of Science” pages 234-252 from Reevaluating the Third Reich edited by Thomas Childers and Jane Caplan, New York: Holmes & Meier, 1994 ISBN 0-8419-1178-9. The German original was published as "Die Genesis der 'Endlösung' aus dem Geist der Wissenschaft," in Max Webers Diagnose der Moderne, edited by Detlev Peukert (Göttingen: Vandenhoeck & Ruprecht, 1989), pages 102–21, ISBN 3-525-33562-8.
The natural progression of NAION following acute vision loss typically includes an improvement in visual acuity by 3 or more lines on the Early Treatment Diabetic Retinopathy Study (ETDRS) chart in 43% of those not receiving treatment. As the initial swelling of the optic disc subsides, optic atrophy generally develops within one to two months after onset. A retrospective diagnosis of optic atrophy due to previous ischemic optic neuropathy is often possible when a small optic disc is detected in both the affected and the opposite eye, and when other tests for potential causes of optic atrophy yield normal results. Following the ischemic damage to one optic disc, there exists a notable risk of involvement of the second eye. The recurrence rate of NAION in the same eye is approximately 6.4%. Data from the trial estimate this risk at about 15% over 5 years. In cases where the second eye also experiences NAION, there is no clear consensus regarding the correlation between the final visual outcomes.
Sources: en.wikipedia.org
The amino acid sequence matches human growth hormone-releasing hormone, but the amino terminus carries a trans-3-hexenoyl group instead of a free amine. That single structural change chiefly affects enzymatic stability rather than receptor selectivity.
Growth hormone released from the pituitary stimulates IGF-1 production in the liver and other tissues, so circulating IGF-1 generally rises during exposure. The size of the rise varies between individuals and depends on baseline hormonal status and other concurrent factors.
Reported imaging studies focus on visceral adipose tissue, where reductions are more consistently observed across trials. Subcutaneous depots show smaller and less reproducible changes, so the two compartments should not be treated as equivalent.
Reversed-phase high-performance liquid chromatography with ultraviolet detection is the standard technique for purity and content. Mass spectrometry provides orthogonal confirmation of identity. The two are normally used together rather than in isolation.